AMDL, Inc.

Cancer test maker reports 88.5% increase in revenues

Published in Health Business Week, June 11th, 2004

AMDL, Inc., (ADL), developer and marketer of tests for the early detection of cancer and other serious diseases, reported results for the 3 months ended March 31, 2004.

AMDL's product revenues for the 3 months ended March 31, 2004, totaled $124,503, an 88.5% increase compared to product revenues of $66,036 for the 3 months ended March 31, 2003.

Net loss for the 3 months ended March 31, 2004, was $564,256 or ($0.03) per share compared to a net loss of $571,033, or ($0.06) per share, for the 3 months ended March 31, 2003.

"The company's primary objective remains receiving U.S. Food and Drug Administration clearance to market its...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2004-06-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry